| SHARE-BASED PAYMENT |
SHARE-BASED PAYMENT 32.1Accounting policies The Company offers share-based compensation plans that may be settled in shares or cash, under which the Company receives services as consideration. The cost of the instruments is measured based on their fair value at the grant date, or at the date of these financial statements in the case of phantom shares. To determine the fair value of stock options, the Company uses the Black-Scholes model. The cost of transactions settled with equity securities is recognized in profit or loss under “Salaries and Benefits”, together with corresponding increase in the “Capital reserve” or “Salaries and social charges” liability for phantom shares, over the period in which performance and/or service condition are met. 32.2Compensation plans The Company has three share-based compensation plans: the Stock Option Plan (“Option Plan”), the Restricted Stock Plan (“RSU”) and the Stock Purchase Plan ("Phantom Shares"). All of them aim to stimulate and promote the alignment of the objectives of the Company, shareholders, management and employees, and mitigate the risks in the generation of value of the Company by the loss of its executives, strengthening their commitment and productivity in the long-term results. During the first quarter of 2025, the Company approved the creation of the first program under its stock option plan, providing for the grant of up to 250,000,000 shares with a vesting period of up to three years. During the second quarter of 2025, the Company partially canceled stock options and restricted stock units (RSUs) that had not yet vested. In accordance with IFRS 2 – Share-based Payment, the Company concluded that, as a result of the cancellation, it was required to accelerate the recognition of the related compensation expense. Accordingly, the remaining amount of previously unrecognized expenses was fully recognized in profit or loss, reflecting the settlement of the Company’s future obligations related to these programs. The movement of the plans is shown below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Number of shares | | | | Description | | Stock option plan | | RSU | | Phantom shares | | Total | | | | | | | | | | | At December 31, 2023 | | 20,521,684 | | | 1,544,065 | | | 246,930 | | | 22,312,679 | | | | | | | | | | | | Granted | | 4,200,000 | | | 1,007,253 | | | — | | | 5,207,253 | | | Exercised | | (3,000) | | | (608,472) | | | (18,177) | | | (629,649) | | | Canceled | | (94,181) | | | (101,824) | | | (47,742) | | | (243,747) | | | At December 31, 2024 | | 24,624,503 | | | 1,841,022 | | | 181,011 | | | 26,646,536 | | | | | | | | | | | | | | | | | | | | Exercised | | — | | | (248,045) | | | — | | | (248,045) | | | Canceled | | (15,787,673) | | | (1,057,181) | | | (82,845) | | | (16,927,699) | | | At December 31, 2025 | | 8,836,830 | | | 535,796 | | | 98,166 | | | 9,470,792 | |
| | | | | | | | | | | | | | | | | December 31, | | Description | | 2025 | | 2024 | | | | | | | Share price (in reais) | | 0.18 | | | 3.54 | | | Weighted average price of the stock option (in reais) | | — | | | 5.97 | | | Weighted average price of the phantom shares (in reais) | | — | | | 10.35 | | | Option plan cash inflow | | — | | 18 | | Flat cash inflow of phantom shares | | — | | 188 | | Total liability related to the phantom shares | | — | | | 36 | | | Income tax related to the transfer of RSU | | 98 | | | 1,439 | | | Number of shares equivalent to RSU IR | | 68,229 | | | 167,093 | |
The expenses of share-based compensation plans are shown below: | | | | | | | | | | | | | | | | | | | | | | | Years ended December 31, | | Description | | 2025 | | 2024 | | 2023 | | | | | | | | | Stock option plan | | 62,030 | | | 38,794 | | | 61,646 | | | RSU | | 8,786 | | | 6,361 | | | 9,093 | | | Phantom shares | | (37) | | | (1,700) | | | 904 | | | | 70,779 | | | 43,455 | | | 71,643 | |
Due to the decrease in the Company’s share price during the year ended December 31, 2025, from R$3.54 (in reais) to R$0.18 (in reais), the estimated liability related to phantom share compensation decreased, resulting in a reversal of expenses recognized in prior periods. 32.3Assumptions 32.3.1Stock option During 2025, the Company did not grant any new awards under its share-based compensation programs, as presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Grant | | Exercise price (in R$) | | Avarege fair value (in R$) | | Volatility | | Expected dividend | | Average rate of return | | Exercise rate per tranche | | Remaining term (in years) | | Purchasing period up to (years) | | Options granted | | Outstanding options | | Options available | | | | | | | | | | | | | | | | | | | | | | | | | December 11, 2009 | | 3.42 | | | 1.93 | | | 47.7 | % | | 1.1 | % | | 8.8 | % | | 25.0 | % | | 0.0 | | 4.0 | | 5,032,800 | | | 180,870 | | | 180,870 | | | March 24, 2011 | | 6.44 | | | 4.16 | | | 54.8 | % | | 1.1 | % | | 12.0 | % | | 25.0 | % | | 0.0 | | 4.0 | | 1,572,000 | | | 84,000 | | | 84,000 | | | April 5, 2011 | | 6.44 | | | 4.16 | | | 54.8 | % | | 1.1 | % | | 12.0 | % | | 25.0 | % | | 0.0 | | 4.0 | | 656,000 | | | 6,200 | | | 6,200 | | | June 30, 2014 | | 19.15 | | | 11.01 | | | 40.6 | % | | 1.1 | % | | 12.5 | % | | 25.0 | % | | 0.0 | | 4.0 | | 2,169,122 | | | 708,993 | | | 708,993 | | | July 1, 2015 | | 14.51 | | | 10.82 | | | 40.6 | % | | 1.1 | % | | 15.7 | % | | 25.0 | % | | 0.0 | | 4.0 | | 627,810 | | | 177,592 | | | 177,592 | | | July 1, 2016 | | 14.50 | | | 10.14 | | | 43.1 | % | | 1.1 | % | | 12.2 | % | | 25.0 | % | | 0.0 | | 4.0 | | 820,250 | | | 280,124 | | | 280,124 | | | July 6, 2017 | | 22.57 | | | 12.82 | | | 43.4 | % | | 1.1 | % | | 10.3 | % | | 25.0 | % | | 0.0 | | 4.0 | | 680,467 | | | 442,796 | | | 442,796 | | | August 8, 2022 | | 11.07 | | | 8.10 | | | 70.0 | % | | — | % | | 13.0 | % | | 25.0 | % | | 0.6 | | 4.0 | | 1,774,418 | | | 864,700 | | | 864,700 | | | August 8, 2022 | | 11.07 | | | 6.40 | | | 68.8 | % | | — | % | | 13.2 | % | | 33.3 | % | | 0.0 | | 3.0 | | 1,514,999 | | | 1,027,448 | | | 1,027,448 | | | August 19, 2022 | | 11.07 | | | 7.39 | | | 67.2 | % | | — | % | | 13.6 | % | | 100.0 | % | | 0.0 | | 1.0 | | 4,900,000 | | | 4,624,480 | | | 4,624,480 | | | August 19, 2022 | | 11.07 | | | 11.54 | | | 74.6 | % | | — | % | | 12.7 | % | | 33.0 | % | | 0.0 | | 5.0 | | 8,900,000 | | | — | | | — | | | July 7, 2023 | | 15.60 | | | 10.80 | | | 75.4 | % | | — | % | | 10.5 | % | | 25.0 | % | | 1.5 | | 4.0 | | 1,800,000 | | | 439,627 | | | 439,627 | | | October 23, 2024 | | 4.04 | | | 3.25 | | | 73.0 | % | | — | % | | 12.9 | % | | 25.0 | % | | 0.0 | | 4.0 | | 2,200,000 | | | — | | | — | | | December 14, 2024 | | 4.17 | | | 2.16 | | | 72.8 | % | | — | % | | 14.8 | % | | 25.0 | % | | 0.0 | | 4.0 | | 2,000,000 | | | — | | | — | | | | | | | | | | | | | | | | | | | | 34,647,866 | | | 8,836,830 | | | 8,836,830 | |
32.3.2RSU During 2025, the Company did not grant any new awards under its share-based compensation programs, as presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Grant | | Exercise rate per tranche | | Fair value (in reais) | | Remaining term (in years) | | Purchasing period up to (years) | | Total granted | | Total not exercised | | | | | | | | | | | | | | | July 7, 2021 | | 25.0 | % | | 42.67 | | | 0.0 | | 4.0 | | 300,000 | | — | | July 7, 2022 | | 25.0 | % | | 11.72 | | | 0.5 | | 4.0 | | 335,593 | | 13,800 | | July 7, 2022 | | 25.0 | % | | 11.72 | | | 0.5 | | 4.0 | | 671,186 | | 38,966 | | July 7, 2023 | | 25.0 | % | | 19.32 | | | 1.5 | | 4.0 | | 500,000 | | 57,774 | | October 23, 2024 | | 25.0 | % | | 5.48 | | | 2.8 | | 4.0 | | 671,502 | | 276,876 | | December 13, 2024 | | 25.0 | % | | 4.17 | | | 2.9 | | 4.0 | | 335,751 | | 148,380 | | | | | | | | | | | 2,814,032 | | 535,796 |
32.3.3Phantom shares | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Grant | | Exercise price (in reais) | | Average fair value of option | | Volatility | | Expected dividend | | Average risk-free rate of return | | Exercise rate per tranche | | Remaining term (in years) | | Purchasing period up to (years) | | Total granted | | Total outstanding | | Options available | | | | | | | | | | | | | | | | | | | | | | | | | August 7, 2018 | | 20.43 | | — | | | 90.8 | % | | 0 | % | | 14.3% | | 25.0% | | 0.0 | | 4.0 | | 707,400 | | | 53,520 | | | 53,520 | | | April 30, 2020 | | 10.35 | | 0.01 | | | 90.8 | % | | 0 | % | | 14.3% | | 33.3% | | 0.0 | | 3.0 | | 3,250,000 | | | 30,696 | | | 30,696 | | | April 30, 2020 | | 10.35 | | 0.04 | | | 86.7 | % | | 0 | % | | 13.9% | | 25.0% | | 0.0 | | 4.0 | | 1,600,000 | | | 12,520 | | | 12,520 | | | August 17, 2021 | | 33.99 | | 0.01 | | | 84.1 | % | | 0 | % | | 13.7% | | 25.0% | | 0.0 | | 4.0 | | 580,000 | | | 1,430 | | | 1,430 | | | | | | | | | | | | | | | | | | | | 6,137,400 | | | 98,166 | | | 98,166 | |
|